{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T23:08:14Z","timestamp":1783120094386,"version":"3.54.6"},"reference-count":35,"publisher":"SAGE Publications","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JHD"],"published-print":{"date-parts":[[2019,4,30]]},"DOI":"10.3233\/jhd-180312","type":"journal-article","created":{"date-parts":[[2019,3,8]],"date-time":"2019-03-08T11:42:39Z","timestamp":1552045359000},"page":"129-143","source":"Crossref","is-referenced-by-count":20,"title":["Cysteamine Protects Neurons from Mutant Huntingtin Toxicity1"],"prefix":"10.1177","volume":"8","author":[{"given":"Nicolas","family":"Arbez","sequence":"first","affiliation":[{"name":"Department of Psychiatry and Behavioral Sciences, Division of Neurobiology, Johns Hopkins University School of Medicine, Baltimore, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine","family":"Roby","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Behavioral Sciences, Division of Neurobiology, Johns Hopkins University School of Medicine, Baltimore, MD, USA"},{"name":"Current address: Nuredis, Menlo Park, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergey","family":"Akimov","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Behavioral Sciences, Division of Neurobiology, Johns Hopkins University School of Medicine, Baltimore, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chelsy","family":"Eddings","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Behavioral Sciences, Division of Neurobiology, Johns Hopkins University School of Medicine, Baltimore, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Ren","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Behavioral Sciences, Division of Neurobiology, Johns Hopkins University School of Medicine, Baltimore, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofang","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Behavioral Sciences, Division of Neurobiology, Johns Hopkins University School of Medicine, Baltimore, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher A.","family":"Ross","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Behavioral Sciences, Division of Neurobiology, Johns Hopkins University School of Medicine, Baltimore, MD, USA"},{"name":"Departments of Neurology, Neuroscience and Pharmacology, Johns Hopkins University School of Medicine, Baltimore, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","reference":[{"issue":"1","key":"10.3233\/JHD-180312_ref1","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/ene.13413","article-title":"Huntington\u2019s disease: A clinical review","volume":"25","author":"McColgan","year":"2018","journal-title":"Eur J Neurol"},{"issue":"15-16","key":"10.3233\/JHD-180312_ref2","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.drudis.2013.02.003","article-title":"Cysteamine: An old drug with new potential","volume":"18","author":"Besouw","year":"2013","journal-title":"Drug Discov Today"},{"issue":"20","key":"10.3233\/JHD-180312_ref3","doi-asserted-by":"crossref","first-page":"8942","DOI":"10.1523\/JNEUROSCI.22-20-08942.2002","article-title":"Therapeutic effects of cystamine in a murine model of Huntington\u2019s disease","volume":"22","author":"Dedeoglu","year":"2002","journal-title":"J Neurosci"},{"issue":"1","key":"10.3233\/JHD-180312_ref4","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0197-0186(01)00060-2","article-title":"Evidence for arole for transglutaminase in Huntington\u2019s disease and the potential therapeutic implications","volume":"40","author":"Karpuj","year":"2002","journal-title":"Neurochem Int"},{"issue":"1","key":"10.3233\/JHD-180312_ref5","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1471-4159.2005.03357.x","article-title":"Cystamine treatment is neuroprotective in the YAC128 mouse model of Huntington disease","volume":"95","author":"Van Raamsdonk","year":"2005","journal-title":"J Neurochem"},{"issue":"6","key":"10.3233\/JHD-180312_ref6","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.neurobiolaging.2005.04.001","article-title":"The protective effects of cystamine in the R6\/2 Huntington\u2019s disease mouse involve mechanisms other than the inhibition of tissue transglutaminase","volume":"27","author":"Bailey","year":"2006","journal-title":"Neurobiol Aging"},{"issue":"5","key":"10.3233\/JHD-180312_ref7","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1172\/JCI27607","article-title":"Cystamine and cys-teamine increase brain levels of BDNF in Huntington disease via HSJ1b and transglutaminase","volume":"116","author":"Borrell-Pages","year":"2006","journal-title":"J Clin Invest"},{"issue":"6","key":"10.3233\/JHD-180312_ref8","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1002\/mds.27010","article-title":"A randomized, double-blini placebo-controlled trial evaluating cysteamine in Huntington\u2019s disease","volume":"32","author":"Verny","year":"2017","journal-title":"Mov Disord"},{"issue":"6","key":"10.3233\/JHD-180312_ref9","doi-asserted-by":"crossref","first-page":"3825","DOI":"10.1074\/jbc.M205812200","article-title":"Cystamine inhibits caspase activity. Implications for the treatment of polyglutamine disorders","volume":"278","author":"Lesort","year":"2003","journal-title":"J Biol Chem"},{"issue":"5529","key":"10.3233\/JHD-180312_ref10","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1126\/science.1059581","article-title":"Loss of huntingtin-mediated BDNF gene transcription in Huntington\u2019s disease","volume":"293","author":"Zuccato","year":"2001","journal-title":"Science"},{"issue":"1","key":"10.3233\/JHD-180312_ref11","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S1474-4422(10)70245-3","article-title":"Huntington\u2019s disease: From molecular pathogenesis to clinical treatment","volume":"10","author":"Ross","year":"2011","journal-title":"Lancet Neurol"},{"issue":"3","key":"10.3233\/JHD-180312_ref12","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1111\/j.1471-4159.2008.05620.x","article-title":"A novel approach to enhancing cellular glutathione levels","volume":"107","author":"Maher","year":"2008","journal-title":"J Neu-rochem"},{"issue":"7498","key":"10.3233\/JHD-180312_ref13","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/nature13136","article-title":"Cystathionine gamma-lyase deficiency mediates neurodegeneration in Huntington\u2019s disease","volume":"509","author":"Paul","year":"2014","journal-title":"Nature"},{"issue":"2","key":"10.3233\/JHD-180312_ref14","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/j.1471-4159.2004.02726.x","article-title":"Cystamine increases L-cysteine levels in Huntington\u2019s disease transgenic mouse brain and in a PC12 model of polyglutamine aggregation","volume":"91","author":"Fox","year":"2004","journal-title":"J Neurochem"},{"issue":"4","key":"10.3233\/JHD-180312_ref15","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1111\/j.1471-4159.2005.03255.x","article-title":"Treatment of YAC128 mice and their wild-type littermates with cystamine does not lead to its accumulation in plasma or brain: Implications for the treatment of Huntington disease","volume":"94","author":"Pinto","year":"2005","journal-title":"J Neurochem"},{"issue":"2","key":"10.3233\/JHD-180312_ref16","doi-asserted-by":"crossref","first-page":"e88284","DOI":"10.1371\/journal.pone.0088284","article-title":"Phosphorylation of mutant huntingtin at serine 116 modulates neuronal toxicity","volume":"9","author":"Watkin","year":"2014","journal-title":"PLoS One"},{"issue":"11","key":"10.3233\/JHD-180312_ref17","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.1093\/hmg\/ddv080","article-title":"HD iPSC-derived neural progenitors accumulate in culture and are susceptible to BDNF withdrawal due to glutamate toxicity","volume":"24","author":"Mattis","year":"2015","journal-title":"Hum Mol Genet"},{"issue":"5","key":"10.3233\/JHD-180312_ref18","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/nn.4532","article-title":"Developmental alterations in Hunt-ington's disease neural cells and pharmacological rescue in cells and mice","volume":"20","author":"HD iPSC Consortium.","year":"2017","journal-title":"Nat Neurosci"},{"issue":"2","key":"10.3233\/JHD-180312_ref19","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.stem.2012.04.027","article-title":"Induced pluripotent stem cells from patients with Huntington\u2019s disease show CAG-repeat-expansion-associated phenotypes","volume":"11","author":"HD iPSC Consortium.","year":"2012","journal-title":"Cell Stem Cell"},{"issue":"47","key":"10.3233\/JHD-180312_ref20","doi-asserted-by":"crossref","first-page":"19238","DOI":"10.1074\/jbc.M117.782300","article-title":"Post-translational modifications clustering within proteolytic domains decrease mutant huntingtin toxicity","volume":"292","author":"Arbez","year":"2017","journal-title":"J Biol Chem"},{"issue":"1","key":"10.3233\/JHD-180312_ref21","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/nm.4003","article-title":"PPAR-delta is repressed in Huntington\u2019s disease, is required for normal neuronal function and can be targeted therapeutically","volume":"22","author":"Dickey","year":"2015","journal-title":"Nat Med"},{"issue":"30","key":"10.3233\/JHD-180312_ref22","doi-asserted-by":"crossref","first-page":"E7081","DOI":"10.1073\/pnas.1801772115","article-title":"N6-Furfuryladenine is protective in Huntington\u2019s disease models by signaling untingtin phosphorylation","volume":"115","author":"Bowie","year":"2018","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.3233\/JHD-180312_ref23","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/978-0-387-75681-3_17","article-title":"Mechanism of neuroprotective function of taurine","volume":"643","author":"Wu","year":"2009","journal-title":"Adv Exp Med Biol"},{"issue":"2","key":"10.3233\/JHD-180312_ref24","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1432-1033.1968.tb00195.x","article-title":"Metal content of cysteamine oxygenase","volume":"4","author":"Cavallini","year":"1968","journal-title":"Eur J Biochem"},{"issue":"10","key":"10.3233\/JHD-180312_ref25","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1038\/sj.cdd.4401662","article-title":"Neuroprotection by BDNF against glutamate-induced apoptotic cell death is mediated by ERK and PI3-kinase pathways","volume":"12","author":"Almeida","year":"2005","journal-title":"Cell Death Differ"},{"issue":"6","key":"10.3233\/JHD-180312_ref26","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1111\/jnc.14476","article-title":"Astrocyte truncated tropomyosin receptor kinase B mediates brain-derived neurotrophic factor anti-apoptotic effect leading to neuroprotection","volume":"146","author":"Saba","year":"2018","journal-title":"J Neurochem"},{"issue":"419","key":"10.3233\/JHD-180312_ref27","doi-asserted-by":"crossref","first-page":"eaal2332","DOI":"10.1126\/scitranslmed.aal2332","article-title":"PPARdelta activation by bexarotene promotes neuroprotection by restoring bioenergetic and quality control homeostasis","volume":"9","author":"Dickey","year":"2017","journal-title":"Sci Transl Med"},{"issue":"29","key":"10.3233\/JHD-180312_ref28","doi-asserted-by":"crossref","first-page":"24460","DOI":"10.1074\/jbc.M112.382226","article-title":"trans-(-)-epsilon-Viniferin increases mitochondrial sirtuin 3 (SIRT3), activates AMP-activated protein kinase (AMPK), and protects cells in models of Huntington Disease","volume":"287","author":"Fu","year":"2012","journal-title":"J Biol Chem"},{"issue":"7","key":"10.3233\/JHD-180312_ref29","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1111\/j.1460-9568.2006.04686.x","article-title":"Cystamine and cysteamine prevent 3-NP-induced mitochondrial depolarization of Huntington\u2019s disease knock-in striatal cells","volume":"23","author":"Mao","year":"2006","journal-title":"Eur J Neurosci"},{"issue":"31","key":"10.3233\/JHD-180312_ref30","doi-asserted-by":"crossref","first-page":"8843","DOI":"10.1073\/pnas.1608264113","article-title":"Transcriptional control of amino acid homeostasis is disrupted in Huntington\u2019s disease","volume":"113","author":"Sbodio","year":"2016","journal-title":"Proc Natl Acad Sci USA"},{"issue":"37","key":"10.3233\/JHD-180312_ref31","doi-asserted-by":"crossref","first-page":"32002","DOI":"10.1074\/jbc.M111.253344","article-title":"Taurine biosynthesis by neurons and astrocytes","volume":"286","author":"Vitvitsky","year":"2011","journal-title":"J Biol Chem"},{"key":"10.3233\/JHD-180312_ref32","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.nbd.2015.07.012","article-title":"Cystamine\/ cysteamine rescues the dopaminergic system and shows neurorestorative properties in an animal model of Parkinson\u2019s disease","volume":"82","author":"Cisbani","year":"2015","journal-title":"Neurobiol Dis"},{"key":"10.3233\/JHD-180312_ref33","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.neulet.2017.10.062","article-title":"The effects of cysteamine in a mouse model of levodopa-induced dyskinesias","volume":"662","author":"David","year":"2018","journal-title":"Neurosci Lett"},{"issue":"3","key":"10.3233\/JHD-180312_ref34","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.nbd.2012.05.020","article-title":"LRRK2 kinase activity mediates toxic interactions between genetic mutation and oxidative stress in a Drosophila model: Suppression by curcumin","volume":"47","author":"Yang","year":"2012","journal-title":"Neurobiol Dis"},{"issue":"50","key":"10.3233\/JHD-180312_ref35","doi-asserted-by":"crossref","first-page":"19176","DOI":"10.1073\/pnas.0606373103","article-title":"ESET\/SETDB1 gene expression and histone H3 (K9) trimethylation in Huntington\u2019s disease","volume":"103","author":"Ryu","year":"2006","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Journal of Huntington's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JHD-180312","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T08:50:46Z","timestamp":1777452646000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JHD-180312"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,30]]},"references-count":35,"journal-issue":{"issue":"2"},"URL":"https:\/\/doi.org\/10.3233\/jhd-180312","relation":{},"ISSN":["1879-6397","1879-6400"],"issn-type":[{"value":"1879-6397","type":"print"},{"value":"1879-6400","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,30]]}}}